H2S-Releasing JAK1-Targeting Molecular Hybrids as a Multifunctional Strategy for Cutaneous Wound Repair

To integrate complementary pharmacological properties relevant to cutaneous wound repair, we designed and synthesized six novel molecular hybrids combining a JAK1-targeting 7H-pyrrolo[2,3-d]pyrimidine scaffold with selected hydrogen sulfide (H2S)-releasing moieties. The compounds were characterized for their H2S-releasing properties and evaluated in human HaCaT keratinocytes, using abrocitinib, a selective JAK1 inhibitor, as a reference compound. Compounds II, III, and V emerged as the most promising derivatives, displaying marked pro-migratory activity in both scratch wound and Transwell assays, with effects exceeding those of the corresponding H2S donors and abrocitinib under the tested conditions. Notably, compounds II, III, and V exhibited distinct cysteine-dependent H2S-release profiles, characterized by a progressive increase followed by a relatively stable plateau during the 30-min amperometric assay performed at 100 µM. Molecular docking studies supported the ability of the selected hybrids to retain key interactions within the JAK1 binding pocket, while highlighting linker-dependent differences in ligand orientation. Further biological characterization showed that compounds II and V modulated the expression of the extracellular matrix-related genes COL1A1, MMP2, and MMP9, whereas compounds II, III, and V attenuated IFN-γ/TNF-α-induced STAT1 phosphorylation with effects comparable to abrocitinib. Under inflammatory conditions, compounds II and V also counteracted the cytokine-induced reduction in COL1A1 expression. Overall, these findings identify compounds II, III, and V as promising multifunctional H2S-releasing molecular hybrids and support the development of H2S-based hybrid pharmacological strategies combining H2S-releasing properties with enhanced keratinocyte migration, modulation of extracellular matrix-related responses, and attenuation of cytokine-induced STAT1 activation.

Authors

Institutions

Publication Details

Journal
Antioxidants
Published
2026-11-19
DOI
https://doi.org/10.3390/antiox15111504
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

H2S-Releasing JAK1-Targeting Molecular Hybrids as a Multifunctional Strategy for Cutaneous Wound Repair

Vincenzo Santagada, Vincenzo Calderone, Ferdinando Fiorino, Beatrice Ulloa Severino et al.
Antioxidants
Wound Healing and Treatments
article

H2S-Releasing JAK1-Targeting Molecular Hybrids as a Multifunctional Strategy for Cutaneous Wound Repair

Vincenzo Santagada, Vincenzo Calderone, Ferdinando Fiorino, Beatrice Ulloa Severino, Francesco Frecentese, Angela Ianaro, Elisa Perissutti, Valentina Citi, Elisa Magli, Rosa Sparaco, Giuseppe Caliendo, Giuseppe Ercolano, Roberta Palladino, Alma Martelli, Barbara Maglione, Benedetta Romano, Eugenia Romano, Pierfrancesco Cinque, Fabio Somma, Giorgia Andreozzi, Lidia Ciriaco, Stefania Vertuccio, Letizia Dani
article en

Abstract

To integrate complementary pharmacological properties relevant to cutaneous wound repair, we designed and synthesized six novel molecular hybrids combining a JAK1-targeting 7H-pyrrolo[2,3-d]pyrimidine scaffold with selected hydrogen sulfide (H2S)-releasing moieties. The compounds were characterized for their H2S-releasing properties and evaluated in human HaCaT keratinocytes, using abrocitinib, a selective JAK1 inhibitor, as a reference compound. Compounds II, III, and V emerged as the most promising derivatives, displaying marked pro-migratory activity in both scratch wound and Transwell assays, with effects exceeding those of the corresponding H2S donors and abrocitinib under the tested conditions. Notably, compounds II, III, and V exhibited distinct cysteine-dependent H2S-release profiles, characterized by a progressive increase followed by a relatively stable plateau during the 30-min amperometric assay performed at 100 µM. Molecular docking studies supported the ability of the selected hybrids to retain key interactions within the JAK1 binding pocket, while highlighting linker-dependent differences in ligand orientation. Further biological characterization showed that compounds II and V modulated the expression of the extracellular matrix-related genes COL1A1, MMP2, and MMP9, whereas compounds II, III, and V attenuated IFN-γ/TNF-α-induced STAT1 phosphorylation with effects comparable to abrocitinib. Under inflammatory conditions, compounds II and V also counteracted the cytokine-induced reduction in COL1A1 expression. Overall, these findings identify compounds II, III, and V as promising multifunctional H2S-releasing molecular hybrids and support the development of H2S-based hybrid pharmacological strategies combining H2S-releasing properties with enhanced keratinocyte migration, modulation of extracellular matrix-related responses, and attenuation of cytokine-induced STAT1 activation.

AntioxidantsVol. 15(11)
University of Pisa (IT), Farmaceutici Damor (Italy) (IT), University of Naples Federico II (IT)
Wound Healing and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon